Clinical Trial Update: A Phase IV, Multi-Center, Open-Label Trial of Sibutramine in Combination With a Hypocaloric Diet in Obese and Overweight Thai Subjects. [Phase 4]

View source ↗

Summary

Phase IV, open-label, multi-center trial evaluating sibutramine in combination with a hypocaloric diet in obese and overweight Thai subjects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Sibutramine (sibutramine)

Snippet

Sponsor: Abbott | Conditions: Obesity | Phase 4 | Status: COMPLETED